Delivery Order SPE2DR25D3202-SPE2DR26F8E2U
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,797.70 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials on November 4, 2025, with completion scheduled for November 5, 2025. This firm fixed-price delivery order, processed without a set-aside designation, represents a competitive procurement supporting federal medical supply requirements. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $3,034.01 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials on December 19, 2025, with an ultimate completion date of December 22, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value transaction supporting federal medical supply needs. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,028.92 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials. The contract is a firm fixed-price delivery order with an ultimate completion date of December 22, 2025, and was awarded on December 19, 2025, without a set-aside designation. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,371.44 for M-M-R II vaccine vials, with an ultimate completion date of May 13, 2025. This firm fixed-price contract, awarded on May 12, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award is non-competitive and will be performed at...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, valued at $1,242.48, with an award date of December 31, 2025 and ultimate completion date of January 2, 2026. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the company's headquarters. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,345.16 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials on August 6, 2025, with an ultimate completion date of August 7, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, serves as...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for M-M-R II vaccine vials valued at $15,511.96 with a firm fixed price contract type. The order is scheduled for completion by December 11, 2025, and will be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $9,195.54 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials on December 8, 2025, with completion expected by December 9, 2025. This firm fixed-price delivery order was not designated as a set-aside contract and represents a competitive award under the company's existing indefinite delivery contract vehicle. Performance will take place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order falls...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,925.33 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials on September 11, 2025. This is a firm fixed price delivery order with an ultimate completion date of September 12, 2025, and represents performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation, consistent with AmerisourceBergen's standard federal procurement...
- The Defense Logistics Agency (DLA) awarded a $1,028.92 delivery order to AmerisourceBergen Drug Corp for M-M-R II vaccine vials on December 8, 2025, with completion scheduled for December 9, 2025. This firm fixed-price contract was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, is...
- SPE2DR25D3202Indefinite Delivery Contract
- SPE2DR25D3202-SPE2DR26F8E2UDelivery Order
The Defense Logistics Agency (DLA) awarded a $1,007.13 delivery order to AmerisourceBergen Drug Corp on December 30, 2025, for M-M-R II vaccine vials. The contract is a firm fixed price delivery order with no set-aside designation, utilizing AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's corporate headquarters and a primary distribution hub for federal medical procurement. This delivery order represents a routine transaction under AmerisourceBergen's comprehensive global pharmaceutical support vehicle, which enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. As a major pharmaceutical distributor, AmerisourceBergen serves as a critical vendor for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems through its DLA contract arrangements. The M-M-R II vaccine order fulfills immediate medical supply requirements within the broader scope of the company's established pharmaceutical prime vendor relationship with the DLA, demonstrating the routine operational nature of delivery orders issued against such master contracts.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 12/29/25 |